The stock market is down Monday, with the Dow Jones Industrial Average down 0.20%, the Nasdaq down 0.04% and the S&P 500 down 0.39%. Today’s sole winner is a pharmaceutical company with a kidney drug that passed a trial, and today’s sole loser announced that its yearly profit will fall short of prior estimates.
This is today’s market winner and loser.
Biggest Winner
Shares of Keryx Biopharmaceuticals Inc. (NASDAQ: KERX) are up 41.40% to $4.85 on trading volume of 10.7 million shares. A kidney disease drug the company is trying to get on the market has passed a late-stage trial. The 52-week high is $5.19.
Biggest Loser
Shares of Jos. A Bank Clothiers Inc. (NASDAQ: JOSB) are down 16.25% to $38.75 on trading volume of 1.7 million shares. The company announced that 2012 profit will fall 20% compared to the prior year because of warmer-than-usual weather and U.S. political unease. Before Monday, the 52-week low was $39.54.
Follow Samuel on Twitter: SWeigley
Credit Card Companies Are Doing Something Nuts
Credit card companies are at war. The biggest issuers are handing out free rewards and benefits to win the best customers.
It’s possible to find cards paying unlimited 1.5%, 2%, and even more today. That’s free money for qualified borrowers, and the type of thing that would be crazy to pass up. Those rewards can add up to thousands of dollars every year in free money, and include other benefits as well.
We’ve assembled some of the best credit cards for users today. Don’t miss these offers because they won’t be this good forever.
Flywheel Publishing has partnered with CardRatings for our coverage of credit card products. Flywheel Publishing and CardRatings may receive a commission from card issuers.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
